Redwire (RDW) Q1 2026 Earnings Call Transcript

Redwire reported Q1 2026 revenue of $97 million, up 57.9% year over year, with gross margin expanding to 26.6% from 14.7% a year ago and backlog reaching a record $498.1 million. The company reaffirmed full-year revenue guidance of $450 million to $500 million and highlighted major wins including the $1.8 billion Andromeda IDIQ, over $20 million in Stalker orders, and a $12.8 million ELSA solar array contract. EBITDA remained negative at $9.2 million, but cash burn improved sharply and liquidity ended at $175.2 million.

Analysis

RDW is transitioning from a contract win story to an option-like capital allocation story. The key second-order effect is that higher IRAD and the ATM are not just funding growth; they are effectively converting future backlog into a higher-probability pipeline in categories with far better pricing power and strategic scarcity. That matters because the market usually underwrites space hardware at a low-quality revenue multiple, but a limited-competition IDIQ with a decade-long monetization window should compress the discount rate if execution stays intact.

The bigger near-term inflection is margin mix, not top-line. Gross margin expansion while operating cash burn falls suggests the company is finally getting operating leverage from maturing programs and from the post-acquisition cleanup, which creates room for valuation rerating before EBITDA turns sustainably positive. The risk is that management is pre-announcing a deliberate sacrifice of near-term EBITDA, so the stock can stall if investors focus on the negative adjusted EBITDA rather than the improving cash conversion and backlog quality.

The hidden bull case is that RDW is becoming a differentiated defense-space prime at exactly the moment budgets are tilting toward multi-orbit resilience. If Golden Dome becomes a portfolio of proliferated, maneuverable, and refuelable systems rather than a single program, Redwire’s portfolio has multiple shots on goal, and the commercial lunar and microgravity pieces add free upside rather than being the core thesis. The main failure mode is execution creep: if IRAD spend outruns contract awards for even 2-3 quarters, the ATM becomes a dilution overhang instead of a growth catalyst.

Key Decisions for Investors

• Long RDW into the next 1-2 quarters on weakness, targeting a re-rate as backlog converts and cash burn stays below $10M/quarter; use a 15-20% trailing stop because the thesis breaks if execution slips.
• Buy RDW calls 3-6 months out instead of common stock if implied vol is reasonable; the setup is convex to another backlog/booking beat, while downside is capped to premium.
• Pair trade: long RDW / short a lower-growth defense integrator over the same horizon to isolate the rerating from margin-mix improvement and reduce beta to broader defense multiples.
• Fade strength only if dilution accelerates: if the ATM is used aggressively before clear contract follow-through, reduce exposure or hedge with short-dated puts ahead of the next print.
• Watch for confirmation in the next two quarters: sustained book-to-bill >1.3 and operating cash burn near breakeven would justify adding on pullbacks; if either rolls over, reassess the entire bull case.